IXC 4.29% 6.7¢ invex therapeutics ltd

Ann: Publication of Invex IIH Phase II Pressure Trial Results, page-16

  1. 941 Posts.
    lightbulb Created with Sketch. 302
    "Patients with a diagnosis of active idiopathic intracranial hypertension were identified and recruited from a single tertiary referral hospital (University Hospitals Birmingham NHS Foundation Trust). "

    You also need to recall that inter cranial pressure was measured differently in this trial. "ICP was recorded using a transdermal telemetric ICP monitoring system" essential this required an implant in to the skull. This is not a nothing and while this provided the most fantastic data it is a lot bigger deal than asking patients to undergo 3 or 4 lumber punctures over 6 months, which in and of itself is also not nothing.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.7¢
Change
-0.003(4.29%)
Mkt cap ! $5.035M
Open High Low Value Volume
7.0¢ 7.0¢ 6.7¢ $9.727K 141.0K

Buyers (Bids)

No. Vol. Price($)
1 10000 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 37500 1
View Market Depth
Last trade - 13.44pm 27/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.